Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 5/2017

27.04.2017 | Original Article

Risk factors for poor bone health in primary mitochondrial disease

verfasst von: Shifa S. Gandhi, Colleen Muraresku, Elizabeth M. McCormick, Marni J. Falk, Shana E. McCormack

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 5/2017

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Primary mitochondrial disease is caused by either mitochondrial or nuclear DNA mutations that impact the function of the mitochondrial respiratory chain. Individuals with mitochondrial disorders have comorbid conditions that may increase their risk for poor bone health. The objective of this retrospective electronic medical record (EMR) review was to examine risk factors for poor bone health in children and adults with primary mitochondrial disease.

Methods

Eighty individuals with confirmed clinical and genetic diagnoses of primary mitochondrial disease at the Children’s Hospital of Philadelphia (CHOP) were included in this study. Risk factors and bone health outcomes were collected systematically, including: anthropometrics (low BMI), risk-conferring co-morbidities and medications, vitamin D status, nutrition, immobility, fracture history, and, where available, dual energy x-ray absorptiometry (DXA) bone mineral density (BMD) results.

Results

Of patients 73% (n = 58) had at least one risk factor and 30% (n = 24) had four or more risk factors for poor bone health. The median number of risk factors per participant was 2, with an interquartile interval (IQI 0–4). In the subset of the cohort who were known to have sustained any lifetime fracture (n = 11), a total of 16 fractures were reported, six of which were fragility fractures, indicative of a clinically significant decrease in bone strength.

Conclusions

The prevalence of risk factors for poor bone health in primary mitochondrial disease is high. As part of supportive care, practitioners should address modifiable risk factors to optimize bone health, and have a low threshold to evaluate clinical symptoms that could suggest occult fragility fracture.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
Zurück zum Zitat Barry DW, Kohrt WM (2008) Exercise and the preservation of bone health. J Cardiopulm Rehabil Prev 28(3):153–162CrossRefPubMed Barry DW, Kohrt WM (2008) Exercise and the preservation of bone health. J Cardiopulm Rehabil Prev 28(3):153–162CrossRefPubMed
Zurück zum Zitat Bishop N et al (2014) Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 pediatric official positions. J Clin Densitom 17(2):275–280CrossRefPubMed Bishop N et al (2014) Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 pediatric official positions. J Clin Densitom 17(2):275–280CrossRefPubMed
Zurück zum Zitat Chinnery PF (1993) Mitochondrial disorders overview. In: Pagon RA et al (ed) GeneReviews(R). University of Washington, Seattle Chinnery PF (1993) Mitochondrial disorders overview. In: Pagon RA et al (ed) GeneReviews(R). University of Washington, Seattle
Zurück zum Zitat Cholley F et al (2001) Mitochondrial respiratory chain deficiency revealed by hypothermia. Neuropediatrics 32(2):104–106CrossRefPubMed Cholley F et al (2001) Mitochondrial respiratory chain deficiency revealed by hypothermia. Neuropediatrics 32(2):104–106CrossRefPubMed
Zurück zum Zitat De Block CE et al (2004) A novel 7301-bp deletion in mitochondrial DNA in a patient with Kearns-Sayre syndrome, diabetes mellitus, and primary amenorrhoea. Exp Clin Endocrinol Diabetes 112(2):80–83CrossRefPubMed De Block CE et al (2004) A novel 7301-bp deletion in mitochondrial DNA in a patient with Kearns-Sayre syndrome, diabetes mellitus, and primary amenorrhoea. Exp Clin Endocrinol Diabetes 112(2):80–83CrossRefPubMed
Zurück zum Zitat Dobson PF et al (2016) Unique quadruple immunofluorescence assay demonstrates mitochondrial respiratory chain dysfunction in osteoblasts of aged and PolgA(−/−) mice. Sci Rep 6:31907CrossRefPubMedPubMedCentral Dobson PF et al (2016) Unique quadruple immunofluorescence assay demonstrates mitochondrial respiratory chain dysfunction in osteoblasts of aged and PolgA(−/−) mice. Sci Rep 6:31907CrossRefPubMedPubMedCentral
Zurück zum Zitat Dosa NP et al (2007) Incidence, prevalence, and characteristics of fractures in children, adolescents, and adults with spina bifida. J Spinal Cord Med 30(Suppl 1):S5–S9CrossRefPubMedPubMedCentral Dosa NP et al (2007) Incidence, prevalence, and characteristics of fractures in children, adolescents, and adults with spina bifida. J Spinal Cord Med 30(Suppl 1):S5–S9CrossRefPubMedPubMedCentral
Zurück zum Zitat Drezner MK (2004) Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 5(Suppl 2):S41–S47CrossRefPubMed Drezner MK (2004) Treatment of anticonvulsant drug-induced bone disease. Epilepsy Behav 5(Suppl 2):S41–S47CrossRefPubMed
Zurück zum Zitat Eigentler A et al (2014) Low bone mineral density in Friedreich ataxia. Cerebellum 13(5):549–557CrossRefPubMed Eigentler A et al (2014) Low bone mineral density in Friedreich ataxia. Cerebellum 13(5):549–557CrossRefPubMed
Zurück zum Zitat Fedorenko M, Wagner ML, Wu BY (2015) Survey of risk factors for osteoporosis and osteoprotective behaviors among patients with epilepsy. Epilepsy Behav 45:217–222CrossRefPubMed Fedorenko M, Wagner ML, Wu BY (2015) Survey of risk factors for osteoporosis and osteoprotective behaviors among patients with epilepsy. Epilepsy Behav 45:217–222CrossRefPubMed
Zurück zum Zitat Gordon CM et al (2014) 2013 pediatric position development conference: executive summary and reflections. J Clin Densitom 17(2):219–224CrossRefPubMed Gordon CM et al (2014) 2013 pediatric position development conference: executive summary and reflections. J Clin Densitom 17(2):219–224CrossRefPubMed
Zurück zum Zitat Grieff M, Bushinsky DA (2011) Diuretics and disorders of calcium homeostasis. Semin Nephrol 31(6):535–541CrossRefPubMed Grieff M, Bushinsky DA (2011) Diuretics and disorders of calcium homeostasis. Semin Nephrol 31(6):535–541CrossRefPubMed
Zurück zum Zitat Harvey JN, Barnett D (1992) Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol 37(1):97–103CrossRef Harvey JN, Barnett D (1992) Endocrine dysfunction in Kearns-Sayre syndrome. Clin Endocrinol 37(1):97–103CrossRef
Zurück zum Zitat Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930CrossRefPubMed Holick MF et al (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(7):1911–1930CrossRefPubMed
Zurück zum Zitat Kalkwarf HJ et al (2007) The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 92(6):2087–2099CrossRefPubMed Kalkwarf HJ et al (2007) The bone mineral density in childhood study: bone mineral content and density according to age, sex, and race. J Clin Endocrinol Metab 92(6):2087–2099CrossRefPubMed
Zurück zum Zitat Kuczmarski RJ et al (2000) CDC growth charts: United States. Adv Data 314:1–27 Kuczmarski RJ et al (2000) CDC growth charts: United States. Adv Data 314:1–27
Zurück zum Zitat Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL (2002) 2000 CDC Growth Charts for the United States: methods and development. Vital and Health Statistics Series 11, Data from the National Health Survey (246):1–190 Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, Mei Z, Wei R, Curtin LR, Roche AF, Johnson CL (2002) 2000 CDC Growth Charts for the United States: methods and development. Vital and Health Statistics Series 11, Data from the National Health Survey (246):1–190
Zurück zum Zitat Lewiecki EM et al (2016) Best practices for dual-energy X-ray absorptiometry measurement and reporting: International Society for Clinical Densitometry Guidance. J Clin Densitom 19(2):127–140CrossRefPubMed Lewiecki EM et al (2016) Best practices for dual-energy X-ray absorptiometry measurement and reporting: International Society for Clinical Densitometry Guidance. J Clin Densitom 19(2):127–140CrossRefPubMed
Zurück zum Zitat Lindsey RC, Mohan S (2016) Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Mol Cell Endocrinol 432:44–55CrossRefPubMed Lindsey RC, Mohan S (2016) Skeletal effects of growth hormone and insulin-like growth factor-I therapy. Mol Cell Endocrinol 432:44–55CrossRefPubMed
Zurück zum Zitat Mazziotti G et al (2016) Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines. Endocrine doi:10.1007/s12020-016-1146-8 Mazziotti G et al (2016) Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines. Endocrine doi:10.1007/s12020-016-1146-8
Zurück zum Zitat McDonald DG et al (2002) Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 44(10):695–698CrossRefPubMed McDonald DG et al (2002) Fracture prevalence in Duchenne muscular dystrophy. Dev Med Child Neurol 44(10):695–698CrossRefPubMed
Zurück zum Zitat Mirza F, Canalis E (2015) Management of endocrine disease: secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 173(3):R131–R151CrossRefPubMedPubMedCentral Mirza F, Canalis E (2015) Management of endocrine disease: secondary osteoporosis: pathophysiology and management. Eur J Endocrinol 173(3):R131–R151CrossRefPubMedPubMedCentral
Zurück zum Zitat Misra M et al (2008) Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122(2):398–417CrossRefPubMed Misra M et al (2008) Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics 122(2):398–417CrossRefPubMed
Zurück zum Zitat Murphy JL et al (2008) Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain 131(Pt 11):2832–2840CrossRefPubMed Murphy JL et al (2008) Resistance training in patients with single, large-scale deletions of mitochondrial DNA. Brain 131(Pt 11):2832–2840CrossRefPubMed
Zurück zum Zitat Panday K, Gona A, Humphrey MB (2014) Medication-induced osteoporosis: screening and treatment strategies. Ther Adv Musculoskelet Dis 6(5):185–202CrossRefPubMedPubMedCentral Panday K, Gona A, Humphrey MB (2014) Medication-induced osteoporosis: screening and treatment strategies. Ther Adv Musculoskelet Dis 6(5):185–202CrossRefPubMedPubMedCentral
Zurück zum Zitat Parikh S et al (2015) Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial Medicine Society. Genet Med 17(9):689–701CrossRefPubMed Parikh S et al (2015) Diagnosis and management of mitochondrial disease: a consensus statement from the mitochondrial Medicine Society. Genet Med 17(9):689–701CrossRefPubMed
Zurück zum Zitat Pavlovic A et al (2013) Relationship of thoracic kyphosis and lumbar lordosis to bone mineral density in women. Osteoporos Int 24(8):2269–2273CrossRefPubMed Pavlovic A et al (2013) Relationship of thoracic kyphosis and lumbar lordosis to bone mineral density in women. Osteoporos Int 24(8):2269–2273CrossRefPubMed
Zurück zum Zitat Shiek Ahmad B et al (2016) Bone mineral changes in epilepsy patients during initial years of antiepileptic drug therapy. J Clin Densitom doi:10.1016/j.jocd.2016.07.008. Shiek Ahmad B et al (2016) Bone mineral changes in epilepsy patients during initial years of antiepileptic drug therapy. J Clin Densitom doi:10.1016/j.jocd.2016.07.008.
Zurück zum Zitat Sinha A et al (2013) Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab 98(3):E509–E513CrossRefPubMed Sinha A et al (2013) Improving the vitamin D status of vitamin D deficient adults is associated with improved mitochondrial oxidative function in skeletal muscle. J Clin Endocrinol Metab 98(3):E509–E513CrossRefPubMed
Zurück zum Zitat Stacpoole PW et al (2012) Design and implementation of the first randomized controlled trial of coenzyme CoQ(1)(0) in children with primary mitochondrial diseases. Mitochondrion 12(6):623–629CrossRefPubMedPubMedCentral Stacpoole PW et al (2012) Design and implementation of the first randomized controlled trial of coenzyme CoQ(1)(0) in children with primary mitochondrial diseases. Mitochondrion 12(6):623–629CrossRefPubMedPubMedCentral
Zurück zum Zitat Toth M, Grossman A (2013) Glucocorticoid-induced osteoporosis: lessons from Cushing’s syndrome. Clin Endocrinol 79(1):1–11CrossRef Toth M, Grossman A (2013) Glucocorticoid-induced osteoporosis: lessons from Cushing’s syndrome. Clin Endocrinol 79(1):1–11CrossRef
Zurück zum Zitat Trifunovic A et al (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429(6990):417–423CrossRefPubMed Trifunovic A et al (2004) Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429(6990):417–423CrossRefPubMed
Zurück zum Zitat Tzoufi M et al (2013) A rare case report of simultaneous presentation of myopathy, Addison’s disease, primary hypoparathyroidism, and Fanconi syndrome in a child diagnosed with Kearns-Sayre syndrome. Eur J Pediatr 172(4):557–561CrossRefPubMed Tzoufi M et al (2013) A rare case report of simultaneous presentation of myopathy, Addison’s disease, primary hypoparathyroidism, and Fanconi syndrome in a child diagnosed with Kearns-Sayre syndrome. Eur J Pediatr 172(4):557–561CrossRefPubMed
Zurück zum Zitat Varanasi SS et al (1999) Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int 10(2):143–149CrossRefPubMed Varanasi SS et al (1999) Mitochondrial DNA deletion associated oxidative stress and severe male osteoporosis. Osteoporos Int 10(2):143–149CrossRefPubMed
Zurück zum Zitat Weaver CM et al (2016) The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int 27(4):1281–1386CrossRefPubMedPubMedCentral Weaver CM et al (2016) The National Osteoporosis Foundation’s position statement on peak bone mass development and lifestyle factors: a systematic review and implementation recommendations. Osteoporos Int 27(4):1281–1386CrossRefPubMedPubMedCentral
Zurück zum Zitat Weber DR et al (2015) Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using the health improvement network (THIN). Diabetes Care 38(10):1913–1920CrossRefPubMedPubMedCentral Weber DR et al (2015) Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using the health improvement network (THIN). Diabetes Care 38(10):1913–1920CrossRefPubMedPubMedCentral
Zurück zum Zitat Weger M et al (1999) Incomplete renal tubular acidosis in ‘primary’ osteoporosis. Osteoporos Int 10(4):325–329CrossRefPubMed Weger M et al (1999) Incomplete renal tubular acidosis in ‘primary’ osteoporosis. Osteoporos Int 10(4):325–329CrossRefPubMed
Zurück zum Zitat Wei SH, Lee WT (2015) Comorbidity of childhood epilepsy. J Formos Med Assoc 114(11):1031–1038CrossRefPubMed Wei SH, Lee WT (2015) Comorbidity of childhood epilepsy. J Formos Med Assoc 114(11):1031–1038CrossRefPubMed
Zurück zum Zitat Whittaker RG et al (2007) Prevalence and progression of diabetes in mitochondrial disease. Diabetologia 50(10):2085–2089CrossRefPubMed Whittaker RG et al (2007) Prevalence and progression of diabetes in mitochondrial disease. Diabetologia 50(10):2085–2089CrossRefPubMed
Zurück zum Zitat Zemel BS et al (2010) Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 95(3):1265–1273CrossRefPubMedPubMedCentral Zemel BS et al (2010) Height adjustment in assessing dual energy x-ray absorptiometry measurements of bone mass and density in children. J Clin Endocrinol Metab 95(3):1265–1273CrossRefPubMedPubMedCentral
Zurück zum Zitat Zemel BS et al (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96(10):3160–3169CrossRefPubMedPubMedCentral Zemel BS et al (2011) Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study. J Clin Endocrinol Metab 96(10):3160–3169CrossRefPubMedPubMedCentral
Metadaten
Titel
Risk factors for poor bone health in primary mitochondrial disease
verfasst von
Shifa S. Gandhi
Colleen Muraresku
Elizabeth M. McCormick
Marni J. Falk
Shana E. McCormack
Publikationsdatum
27.04.2017
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 5/2017
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-017-0046-2

Weitere Artikel der Ausgabe 5/2017

Journal of Inherited Metabolic Disease 5/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhöhte Mortalität bei postpartalem Brustkrebs

07.05.2024 Mammakarzinom Nachrichten

Auch für Trägerinnen von BRCA-Varianten gilt: Erkranken sie fünf bis zehn Jahre nach der letzten Schwangerschaft an Brustkrebs, ist das Sterberisiko besonders hoch.

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Vorhofflimmern bei Jüngeren gefährlicher als gedacht

06.05.2024 Vorhofflimmern Nachrichten

Immer mehr jüngere Menschen leiden unter Vorhofflimmern. Betroffene unter 65 Jahren haben viele Risikofaktoren und ein signifikant erhöhtes Sterberisiko verglichen mit Gleichaltrigen ohne die Erkrankung.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.